Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Protagonist Therapeutics stock hits all-time high at 105.71 USD By Investing.com
Protagonist Therapeutics (PTGX) stock has reached an all-time high of $105.71, currently trading at $105.99, demonstrating a 125.11% increase over the past year. Analysts predict profitability this year with earnings of $3.78 per share, despite the stock appearing overvalued. Recent FDA approval for its psoriasis drug, Icotyde, has further boosted investor confidence and led to multiple analyst price target increases.